Global Neurosciences Institute (GNI) neurosurgeon Rudy Rahme, MD, FAANS, performed the first SetPoint® System procedures in South Jersey on September 9, 2026 at AtlantiCare Regional Medical Center in Atlantic City.

The SetPoint System is an FDA-approved treatment for adults with moderately to severely active rheumatoid arthritis who have had an inadequate response, loss of response, or intolerance to one or more biologic or targeted synthetic disease-modifying antirheumatic drugs. GNI is the only group in South Jersey, Pennsylvania and Delaware offering the therapy.

The full media release will be published on Monday, September 28, 2026.

To refer a patient or ask whether the SetPoint System may be an option for you, call GNI at 844-464-6387 or request an appointment online. Learn more about Dr. Rahme.

SetPoint® System is a registered trademark of SetPoint Medical.